Haegarda for the Preventive Treatment of Hereditary Angioedema

Haegarda ® (C1 Esterase Inhibitor) a subcutaneous prophylactic therapy indicated for the prevention of hereditary angioedema (HAE) attacks in adolescent and adult patients.

Source: Drug Development Technology - July 12, 2017 Category: Pharmaceuticals Source Type: news